Skip to main content
Log in

Augmentation of 5-fluorouracil cytotoxicity by epidermal growth factor in a newly established human signet-ring cell carcinoma of the stomach in culture

  • Original Articles
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

A cell line designated TSG6 was established from a signet-ring cell gastric carcinoma developed in a 57-year-old female patient. The TSG6 cells had well preserved the features of signet-ring cell carcinoma based on morphology. The cells exhibited both epidermal growth factor (EGF) and epidermal growth factor receptor (EGFR) immunoreactivities, and also secreted EGF. Moreover, the growth of TSG6 cells was stimulated in the presence of exogenous EGF. These results suggest that the possible presence of an EGF/EGFR autocrine growth mechanism is expressed in the TSG6 cells. The simultaneous treatment with EGF and 5-fluorouracil (5-FU) produced a nearly 2.4-fold enhancement of 5-FU cytotoxicity against TSG6 cells. A bromodeoxyuridine/DNA How cytometry analysis revealed that EGF augmented 5-FU cytotoxicity by inducing the accumulation of S phase cells which might be more susceptible to 5-FU. Moreover, we found that the incorporation of 5-FU into the TSG6 cells was increased with the addition of EGF. These data indicate that EGF may be a potent agent as a biological response modifier for 5-FU against the tumors which express the EGF/EGFR autocrine mechanism, and that the TSG6 cell line is useful in furthering our understanding of the interaction between anticancer drugs and EGF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Furukawa H, Hiratsuka M, Iwanaga T (1988) A rational technique for surgical operation on Borrmann type 4 gastric carcinoma: left upper abdominal evisceration plus Appleby's method. Br J Surg 75:116–119

    PubMed  Google Scholar 

  2. Tahara E (1990) Growth factors and oncogenes in human gastrointestinal carcinomas. J Cancer Res Clin Oncol 116:121–131

    PubMed  Google Scholar 

  3. Haruma K, Yoshihara M, Tanaka S, Sumii K, Kajiyama G, Hidaka T, Daitoku K, Matsumoto T (1992) Rapid growth and difficulty of early detection of scirrhous carcinoma of the stomach. Am J Gastroenterol 87:31–36

    PubMed  Google Scholar 

  4. Hojo H (1977) Establishment of cultured cell lines of human stomach cancer — Origin and their morphological characteristics (in Japanese). Niigata Igakukai Zasshi (Niigata Med J) 91:737–752

    Google Scholar 

  5. Motoyama T, Hojo H, Watanabe H (1986) Comparison of severn cell lines derived from human gastric carcinomas. Acta Pathol Jpn 36:65–83

    PubMed  Google Scholar 

  6. Park JG, Frucht H, LaRocca RV, Bliss DP Jr, Kurita Y, Chen TR, Henslee JG, Trepel JB, Jensen RT, Johnson BE, Bang YJ, Kim JP, Gazdar AF (1990) Characteristics of cell lines established from human gastric carcinoma. Cancer Res 50:2773–2780

    PubMed  Google Scholar 

  7. Sekiguchi M, Sakakibara K, Fujii G (1978) Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn J Exp Med 48:61–68

    PubMed  Google Scholar 

  8. Dippold WG, Kron G, Boosfeld E, Dienes HP, Klingel R, Knuth T, Wagner R, Meyer zum Büschenfelde KH (1987) Signet ring stomach cancer: morphological characterization and antigenic profile of a newly established cell line (Mz-Sto-1). Eur J Cancer Clin Oncol 23:697–706

    PubMed  Google Scholar 

  9. Yanagihara K, Seyama T, Tsumuraya M, Kamada M, Yokoro K (1991) Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. Cancer Res 51:381–386

    PubMed  Google Scholar 

  10. Bertsch S, Marks F (1979) Effects of epidermal chalone and epidermal growth factor on a transplantable epidermal carcinoma (Hewitt) of the mouse in vivo. Cancer Res 39:239–243

    PubMed  Google Scholar 

  11. Schabel FM Jr, Simpson-Herren L (1984) Tumor growth kinetics and drug treatment of cancer. In: Kuemmerle HP, Berkada B, Karrer K, Mathé G (eds) Clinical chemotherapy: vol. 3: Antineoplastic chemotherapy. Thieme-Stratton, New York, pp 16–34

    Google Scholar 

  12. Dolbeare F, Gratzner H, Pallavicini MG, Gray JW (1983) Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci USA 80:5573–5577

    PubMed  Google Scholar 

  13. Marunaka T, Umeno Y (1978) Quantitative determination of 1,3-bis (tetrahydro-2-furanyl)-5-fluoro-2, 4-pyrimidinedione and its metabolites in plasma by high-pressure liquid chromatography and gas chromatography-mass fragmentography. J Chromatogr 157:321–330

    PubMed  Google Scholar 

  14. Motoyama, T, Hojo H, Suzuki T, Oboshi S (1979) Evaluation of the regrowth assay method as an in vitro drug sensitivity test and its application to cultured human gastric cancer cell lines. Acta Med et Biol 27:49–63

    Google Scholar 

  15. Sporn MB, Todaro GJ (1980) Autocrine secretion and malignant transformation of cells. N Engl J Med 303:878–880

    PubMed  Google Scholar 

  16. Cross M, Dexter TM (1991) Growth factors in development, transformation, and tumorigenesis. Cell 64:271–280

    PubMed  Google Scholar 

  17. Santon JB, Cronin MT, MacLeod CL, Mendelsohn J, Masui H, Gill GN (1986) Effects of epidermal growth factor receptor concentration on tumorigenicity of A431 cells in nude mice. Cancer Res 46:4701–4705

    PubMed  Google Scholar 

  18. Yasui W, Hata J, Yokozaki H, Nakatani H, Ochiai A, Ito H, Tahara E (1988) Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma. Int J Cancer 41:211–217

    PubMed  Google Scholar 

  19. Murphy LC, Murphy LJ, Dubik D, Bell GI, Shia RP (1988) Epidermal growth factor gene expression in human breast cancer cells: regulation of expression by progestins. Cancer Res 48: 4555–4560

    PubMed  Google Scholar 

  20. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, Berger WH (1987) Synthesis of messenger RNAs for transforming growth factor a and β and the epidermal growth factor receptor by human tumors. Cancer Res 47:707–712

    PubMed  Google Scholar 

  21. Mydlo JH, Michaeli J, Cordon-Cardo C, Goldenberg AS, Heston WDW, Fair WR (1989) Expression of transforming growth factor a and epidermal growth factor receptor messenger RNA in neoplastic and non-neoplastic human kidney tissue. Cancer Res 49:3407–3411

    PubMed  Google Scholar 

  22. Stromberg K, Collins TJ IV, Gordon AW, Jackson CL, Johnson GR (1992) Transforming growth factor-α acts as an autocrine growth factor in ovarian carcinoma cell lines. Cancer Res 52: 341–347

    PubMed  Google Scholar 

  23. Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A, Minna JD (1985) Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 316:823–826

    PubMed  Google Scholar 

  24. Macauly VM, Teale JD, Everard MJ, Joshi GP, Smith IE, Millar JL (1988) Somatomedin-C/insulin-like growth factor-I is a mitogen for human small cell lung cancer. Br J Cancer 57:91–93

    PubMed  Google Scholar 

  25. Yoshida K, Takanashi A, Kyo E, Ito M, Ito H, Niimoto M, Hattori T, Tahara E (1989) Epidermal growth factor induces the expression of its receptor gene in human gastric carcinoma cell line TMK-1. Jpn J Cancer Res 80:743–746

    PubMed  Google Scholar 

  26. Yoshida K, Kyo E, Tsujino T, Sano T, Niimoto M, Tabara E (1990) Expression of epidermal growth factor, transforming growth factor-α. and their receptor genes in human gastric carcinomas; implication for autocrine growth. Jpn J Cancer Res 81:43–51

    PubMed  Google Scholar 

  27. Tahara E, Sumiyoshi H, Hata J, Yasui W, Taniyama K, Hayashi T, Nagase S, Sakamoto S (1986) Human epidermal growth factor in gastric carcinoma as a biologic marker of high malignancy. Jpn J Cancer Res 77:145–152

    PubMed  Google Scholar 

  28. Yamamoto T, Hattori T, Tahara E (1988) Interaction between transforming growth factor-alpha and c-Ha-ras p21 in progression of human gastric carcinoma. Pathol Res Pract 183:663–669

    PubMed  Google Scholar 

  29. Kamata N, Chida K, Rikimaru K, Horikoshi M, Enomoto S, Kuroki T (1986) Growth-inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture. Cancer Res 46:1648–1653

    PubMed  Google Scholar 

  30. Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD, Seeburg PH (1984) Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309:418–425

    PubMed  Google Scholar 

  31. Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield MD, Ullrich A, Schlessinger J (1985) Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 313:144–147

    PubMed  Google Scholar 

  32. Sakai K, Mori S, Kawamoto T, Taniguchi S, Kobori O, Morioka Y, Kuroki T, Kano K (1986) Expression of epidermal growth factor receptors on normal human gastric epithelia and gastric carcinomas. J Natl Cancer Inst 77:1047–1052

    PubMed  Google Scholar 

  33. Hwang DL, Tay YC, Lin SS, Lev-Ran A (1986) Expression of epidermal growth factor receptors in human lung tumors. Cancer 58:2260–2263

    PubMed  Google Scholar 

  34. Amagase H, Kakimoto M, Hashimoto K, Fuwa T, Tsukagoshi S (1989) Epidermal growth factor receptor-mediated selective cytotoxicity of antitumor agents toward human xenografts and murine syngeneic solid tumors. Jpn J Cancer Res 80:670–678

    PubMed  Google Scholar 

  35. Kwok TT, Sutherland RM (1991) Differences in EGF related radio-sensitisation of human squamous carcinoma cells with high and low numbers of EGF receptors. Br J Cancer 64:251–254

    PubMed  Google Scholar 

  36. Carpenter G, Cohen S (1979) Epidermal growth factor. Ann Rev Biochem 48:193–216

    PubMed  Google Scholar 

  37. Brunk U, Schellens J, Westermark B (1976) Influence of epidermal growth factor (EGF) on ruffling activity, pinocytosis and proliferation of cultivated human glia cells. Exp Cell Res 103:295–302

    PubMed  Google Scholar 

  38. Hollenberg MD, Cuatrecasas P (1973) Epidermal growth factor: receptors in human fibroblasts and modulation of action by cholera toxin. Proc Natl Acad Sci USA 70:2964–2968

    PubMed  Google Scholar 

  39. Armelin H (1973) Pituitary extracts and steroid hormones in the control of 3T3 cell growth. Proc Natl Acad Sci USA 70:2702–2706

    PubMed  Google Scholar 

  40. Pinedo HM, Peters GFJ (1988) Fluorouracil: biochemistry and pharmacology. J Clin Oncol 6:1653–1664

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aizawa, K., Muto, I., Suzuki, S. et al. Augmentation of 5-fluorouracil cytotoxicity by epidermal growth factor in a newly established human signet-ring cell carcinoma of the stomach in culture. Surg Today 24, 420–428 (1994). https://doi.org/10.1007/BF01427035

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01427035

Key Words

Navigation